- Home
- CLLS
CLLS
Cellectis S.A.
as 11-14-2025 3:27pm EST
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
| Founded: | 1999 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | 299.0M | IPO Year: | 2007 |
| Target Price: | $8.00 | AVG Volume (30 days): | 73.5K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.10 - $5.48 | Next Earning Date: | 11-07-2025 |
| Revenue: | $82,551,000 | Revenue Growth: | 129.04% |
| Revenue Growth (this year): | -12.05% | Revenue Growth (next year): | 58.00% |
Latest Cellectis S.A. News
CLLS Breaking Stock News: Dive into CLLS Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Simply Wall St.
4 days ago
European Penny Stocks To Watch: AFYREN SAS Leads The Pack
MT Newswires
5 days ago
European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading
MT Newswires
7 days ago
Cellectis Q3 Swings to Profit, Revenue Rises
GlobeNewswire
7 days ago
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
8 days ago
Monthly information on share capital and company voting rights
MT Newswires
8 days ago
European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading; Down Modestly for Week
MT Newswires
10 days ago
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Compare CLLS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLLS Cellectis S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.